Shionogi & Co., Ltd is a leading Japanese pharmaceutical company that specializes in the research, development, and commercialization of innovative pharmaceutical products. The company was founded in 1878 and is headquartered in Osaka, Japan. Shionogi's mission is to contribute to the health and well-being of people around the world by providing innovative and high-quality pharmaceutical products.

Shionogi operates in the specialty pharma sector, which is a highly competitive and rapidly evolving industry. The company's focus is on developing and commercializing products in the areas of infectious diseases, pain management, and oncology. Shionogi has a strong research and development pipeline, with a number of promising products in various stages of development.

As a responsible corporate citizen, Shionogi is committed to decarbonisation and reducing its environmental impact. The company has set ambitious targets to reduce its greenhouse gas emissions and increase its use of renewable energy. Shionogi is actively pursuing a number of initiatives to achieve these goals.

One of the key initiatives that Shionogi is pursuing is corporate energy management. The company is implementing a range of measures to improve the energy efficiency of its operations and reduce its energy consumption. This includes the use of energy-efficient lighting and HVAC systems, as well as the installation of solar panels and other renewable energy sources.

Shionogi is also exploring the use of corporate power purchase agreements (PPAs) to increase its use of renewable energy. PPAs allow companies to purchase renewable energy directly from renewable energy providers, often at a lower cost than traditional energy sources. Shionogi is actively seeking out opportunities to enter into PPAs with renewable energy providers in order to increase its use of renewable energy.

In addition to these initiatives, Shionogi is also investing in research and development of new technologies and products that can help to reduce its environmental impact. The company is exploring the use of new materials and manufacturing processes that are more environmentally friendly, as well as developing new products that can help to reduce energy consumption and greenhouse gas emissions.

Overall, Shionogi is committed to being a responsible corporate citizen and reducing its environmental impact. The company's focus on corporate energy management, corporate PPAs, and renewable energy is a testament to its commitment to sustainability and its desire to be a leader in the pharmaceutical industry. As the company continues to grow and evolve, it will undoubtedly continue to pursue innovative and sustainable solutions to the challenges facing the industry and the world as a whole.